Skip to content

The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Trial

The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01543789
Acronym
FUN
Enrollment
44
Registered
2012-03-05
Start date
2012-03-31
Completion date
2023-12-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Umbilical Hernia

Keywords

Umbilical Hernia

Brief summary

The use of mesh in the repair of umbilical hernias is a gold standard. The best location of the mesh remains a matter of discussion, i.e. it might be placed inside the peritoneal cavity (open intraperitoneal onlay mesh) or between the peritoneum and the muscle layers, so not in contact with the viscera (retromuscular or preperitoneal). The Rebound mesh consists of polypropylene, i.e. the most used fabric for meshes, in combination with a nitinol memory ring. This ring allows the surgeon to position the mesh more flat, with less wrinkling and subsequently better tissue ingrowth. It also saves time for both patient's anesthesia and the surgery. This type of mesh (one coated with PTFE for intra-abdominal use and one pure polypropylene for preperitoneal use), will be used in this multicentric trial, to evaluate the best procedure in terms of efficacy, safety and postoperative complications.

Interventions

PROCEDUREIntraperitoneal mesh placement

Mesh placement inside the peritoneal cavity.

PROCEDUREPreperitoneal mesh placement

Mesh placement between peritoneum and muscle layer.

Sponsors

Medri
CollaboratorUNKNOWN
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* written informed consent from the patient or his/her legal representative * primary umbilical hernia requiring elective surgical repair * diameter between 0 and 3 cm

Exclusion criteria

* no written informed consent * incisional hernia at the level of the umbilicus * recurrent umbilical hernia, as they have to be considered an incisional hernia * emergency surgery (incarcerated hernia) * pregnancy * non-compliance

Design outcomes

Primary

MeasureTime frameDescription
Operation time between preperitoneal mesh placement versus intraperitoneal mesh placement.Total duration of the operation with an expected average of approximately 45 minutes.Time registration of the operating time will be extracted from the hospital electronic patient files.

Secondary

MeasureTime frameDescription
Surgical wound morbidity complication rate.Up to 1 year.
Recurrence Rateup to 2 yearsClinical examination will be performed. No ultrasound, unless doubt about recurrence.
Pain evaluationwithin 2 weeks prior to surgery, after 4 weeks, after 1 year and after 2 yearsA questionnaire and Visual Analog Scale (VAS) will be filled out. The patient is asked whether he or she has pain. Answer NO: VAS = 0, Yes: patient will determine the exact VAS score.
Discomfort evaluation.Within 2 weeks prior to surgery, after 4 weeks, after 1 year and after 2 years.A questionnaire and Visual Analog Scale (VAS) will be filled out. The patient is asked whether he or she has discomfort. Answer NO: VAS = 0, Yes: patient will determine the exact VAS score.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026